An integral part of the antiviral innate immune response is the APOBEC3 family of single-stranded DNA 33 cytosine deaminases, which inhibits virus replication through deamination-dependent and -independent 34 activities. Viruses have evolved mechanisms to counteract these enzymes such as HIV-1 Vif-mediated 35 formation of a ubiquitin ligase to degrade virus-restrictive APOBEC3 enzymes. A new example is 36 Epstein-Barr virus (EBV) ribonucleotide reductase (RNR)-mediated inhibition of cellular APOBEC3B 37 (A3B). The large subunit of the viral RNR, BORF2, causes A3B relocalization from the nucleus to 38 cytoplasmic bodies and thereby protects viral DNA during lytic replication. Here, we use 39 co-immunoprecipitation and immunofluorescent microscopy approaches to ask whether this mechanism is 40 shared with the closely related -herpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV) and the 41 more distantly related α-herpesvirus, herpes simplex virus-1 (HSV-1). The large RNR subunit of KSHV, 42 ORF61, co-precipitated multiple APOBEC3s including A3B and APOBEC3A (A3A). KSHV ORF61 also 43 caused relocalization of these two enzymes to perinuclear bodies (A3B) and to oblong cytoplasmic 44 structures (A3A). The large RNR subunit of HSV-1, ICP6, also co-precipitated A3B and A3A and was 45 sufficient to promote the relocalization of these enzymes from nuclear to cytoplasmic compartments. 46 HSV-1 infection caused similar relocalization phenotypes that required ICP6. However, unlike the 47 infectivity defects previously reported for BORF2-null EBV, ICP6 mutant HSV-1 showed normal growth 48 rates and plaque phenotypes. These results combine to indicate that both and α-herpesviruses use a 49 conserved RNR-dependent mechanism to relocalize A3B and A3A and, further, suggest that HSV-1 50 possesses at least one additional mechanism to neutralize these antiviral enzymes. 51 52 Importance 53
Introduction
microscopy observations were made using the same constructs in HeLa cells. These new results combined 131 to indicate that both A3B and A3A are cellular targets of EBV BORF2 and KSHV ORF61. The potential 132 relevance of these interactions to the pathogenesis of these viruses will be considered in the Discussion. 133 134
HSV-1 ICP6 binds and relocalizes A3B and A3A 135
To test whether the RNR-mediated A3B/A relocalization mechanism is more broadly conserved, 136 a series of co-IP experiments was done with the large RNR subunit of the pathogenic -herpesvirus HSV-137 1, ICP6. FLAG-ICP6 was co-expressed with each of the seven different HA-tagged human A3s in 293T 138 cells and subjected to anti-FLAG IP as above. The EBV BORF2-A3B interaction was used as a positive 139 control and BORF2-A3G as a negative control to be able to compare the relative strengths of pulldowns 140 between RNRs and A3s. HSV-1 ICP6 showed a strong interaction with A3A and weaker, but detectable, 141 interactions with A3B, A3C, and A3D (Fig 4A) . 142
Next, IF microscopy was used to assess functional interactions between HSV-1 ICP6 and each of 143 the human A3 enzymes. Human U2OS osteosarcoma cells were co-transfected with mCherry-tagged A3s 144 and either empty vector or FLAG-tagged HSV-1 ICP6 and analyzed by IF after 48 hours (Fig 4B) . On its 145 own EBV BORF2 shows a cytoplasmic distribution and, as shown above and previously (18), it was able 146 to completely relocalize A3B from the nucleus to cytoplasm. In comparison, HSV-1 FLAG-ICP6 showed 147 a broadly cytoplasmic localization that did not change significantly with co-expression of any A3. 148
However, co-expression of FLAG-ICP6 and A3B-mCherry or A3A-mCherry led to a near complete 149 relocalization of these DNA deaminases from the nucleus to the cytoplasm. HSV-1 ICP6 did not cause 150 significant relocalization of any of the other A3s. The dramatic relocalization results with A3B and A3A 151 suggested that functionally relevant interactions may be occurring with these enzymes. 152
153

HSV-1 infection relocalizes A3B, A3A, and A3C 154
To address whether HSV-1 infection similarly promotes relocalization of A3B and A3A, U2OS 155 cells were transfected with A3-mCherry constructs 48 hours prior to either mock or HSV-1 infection. We 156 used K26GFP, a HSV-1 strain that has a GFP moiety fused to capsid protein VP26 to allow for ( Supplementary Fig 2) . This analysis confirmed that HSV-1 infection leads to significant changes in 165 both A3A and A3B localization, whereas A3G is unaffected. Similar relocalization patterns were found in 166 Fig 3) . Moreover, time-course 167 experiments showed that relocalization of A3A was detectable as early as 3 hpi, whereas A3B and A3C 168 relocalization became apparent by 6 or 9 hpi (Supplementary Fig 4) . These kinetic differences may 169 reflect a differential affinity of the viral protein(s) to bind to these cellular A3 enzymes and/or different 170 competitions with cellular interactors. 171
HeLa cells following HSV-1 K26GFP infection (Supplementary
172
HSV-1-mediated relocalization of A3B and A3A requires ICP6 173
To investigate whether the HSV-1 large RNR subunit is required for A3A/B/C relocalization, we 174 next examined A3 localization in cells following infection with an HSV-1 KOS1.1 strain lacking ICP6 175 due to a deletion of the UL39 gene (UL39 encodes ICP6) (28). Vero cells were transfected with 176 A3-mCherry constructs 48 hours prior to mock infection or infection with KOS1.1 or KOSΔICP6. After 8 177 hours, cells were fixed, permeabilized, and subjected to IF analysis by staining for the HSV-1 immediate 178 early protein ICP27 to mark infected cells, and monitoring A3 localization through mCherry fluorescence. 179
As above, HSV-1 infection caused the relocalization of A3A, A3B, and A3C (Fig 6A) . However, only the 180 relocalization A3A and A3B was ICP6-dependent, whereas A3C redistributed regardless of the presence 181 of ICP6. Quantification of A3A and A3B relocalization showed that these proteins were not significantly 182 changed upon KOS1.1ΔICP6 infection compared to mock-infected cells (Supplementary Fig 2) . These 183 results provide strong support for mechanistic conservation of the RNR large subunit interaction with 184 A3A and A3B and also indicate that A3C relocalization by HSV-1 is mechanistically distinct. 185
To further investigate the role of ICP6 in mediating A3A and A3B relocalization, U2OS cells 186 were infected with an HSV-1 KOS mutant with a deletion in the ICP4 gene (29). ICP4, an immediate 187 early protein, is the major transcriptional activator protein of HSV-1 (29). ICP4-null mutants exhibit a 188 strict block to expression of nearly all viral delayed-early and late genes, but are competent to express the 189 viral immediate-early genes (ICP0, ICP22, UL54, and US12) as well as the UL39 gene, a delayed-early 190 gene that is uniquely transactivated by ICP0 (30). In fact, at intermediate and late times post-infection, 191
ICP4-null mutants express abnormally high levels of these immediate early proteins as well as ICP6 (29). 192
Similar to what was seen for wild-type HSV-1 infection, infection with the HSV-1 KOS∆ICP4 mutant 193 also led to A3A and A3B relocalization, but with noticeably more pronounced phenotypes (Fig 6B and  194   Supplementary Fig 2) . For instance, this mutant virus caused A3B-mCherry to form perinuclear 195 aggregates reminiscent of previously observed BORF2-A3B bodies (18) (Fig 6B) . Interestingly, A3C 196 localization became predominantly nuclear upon HSV-1 KOSΔICP4 infection, suggesting that one of the 197 other four immediate early proteins besides ICP4 induces its relocalization. Taken together, these data show that HSV-1 ICP6 is both necessary and sufficient for the relocalization of A3A and A3B, and that at 199 least one other viral factor is responsible for A3C relocalization. Identification of this factor will be the 200 subject of a future investigation. 201 202
Effect of A3B and A3A on HSV-1 replication 203
We next sought to test the effect of A3 expression on HSV-1 virus replication, with or without 204 ICP6. HFF-1 cells were stably transduced to express HA-tagged A3 constructs and then infected at a low 205 MOI (0.001 PFU/cell) with wild-type HSV-1 KOS1.1 or KOSΔICP6. At 48 hpi, the cultures were 206 harvested, and after freeze-thawing to release infectious progeny, the cell lysates were titered on Vero 207 cells to compare virus production. As previously described, KOSΔICP6 exhibited a 1-2 log defect in virus 208 replication compared to wild-type KOS (28). However, there was no significant difference in either 209
KOS1.1 or KOSΔICP6 virus titers produced from control HFF-1 cells or HFF-1 cells expressing different 210
A3 family members ( Supplementary Fig 5A) . 211
To further test whether A3B or A3A can restrict HSV-1 replication, we performed plaque assays 212 on either U2OS or Vero cells stably transduced with HA-tagged A3 constructs. Confluent monolayers 213
were incubated with serial dilutions of KOS1.1 or KOSΔICP6 and incubated for 3 days to allow for 214 plaque formation. However, expression of A3A or A3B did not have a discernable effect on the number 215 or size of KOS1.1 or KOSΔICP6 plaques (Supplementary Fig 5B) . These data suggest that even without 216 ICP6, HSV-1 is not readily susceptible to restriction by A3A or A3B, possibly because it possesses other 217 defenses against these virus restriction factors. 218 219 Discussion 220
We previously described a novel mechanism for A3B counteraction by the γ-herpesvirus RNR 221 large subunits, EBV BORF2 and KSHV ORF61 (18). These viral proteins interact directly with A3B, 222 inhibit its DNA deaminase activity, and relocalize it from the nuclear to the cytoplasmic compartment. 223
The importance of this A3B counteraction mechanism is evidenced by BORF2-null EBV eliciting lower 224 viral titers, decreased infectivity, and an accumulation of A3B signature C/G-to-T/A mutations. Here, we 225 investigated the question of specificity by comparing interactions with the full repertoire of seven 226 different human A3 enzymes, and we also addressed the potential for broader conservation by asking 227 whether the α-herpesvirus HSV-1 possesses a similar APOBEC3 relocalization mechanism. Although 228 EBV BORF2 and KSHV ORF61 were able to interact with several different A3 proteins in co-IP 229 experiments, these viral RNR large subunits only promoted the relocalization of A3B and A3A. HSV-1 230 ICP6 showed a similarly broad range of co-IP interactions but also only promoted the relocalization of relocalization phenotypes. These studies combine to indicate that human and -herpesviruses possess a 233 conserved A3B/A relocalization mechanism mediated by the viral RNR large subunit. 234
The and -herpesvirus subfamilies encode both large and small RNR subunits (Fig 1A) . These 235
RNRs are thought to serve the canonical function of synthesizing deoxyribonucleotides by reducing the 236 
